Patents by Inventor Vinod Kumar GOYAL

Vinod Kumar GOYAL has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Pyrrolo[1,2-b]-2-pyridazinone compounds as 5-HT4 receptor agonists
    Patent number: 12275746
    Abstract: The present invention relates to pyrrolo[1,2-b]-2-pyridazinone compounds of formula (I), or their isotopic forms, stereoisomers, or pharmaceutically acceptable salts thereof as 5-HT4 receptor agonists. The present invention also describes methods of making such compounds, pharmaceutical compositions comprising such compounds, and their use in the treatment of gastrointestinal disease or disorder.
    Type: Grant
    Filed: January 10, 2023
    Date of Patent: April 15, 2025
    Assignee: SUVEN LIFE SCIENCES LIMITED
    Inventors: Ramakrishna Nirogi, Anil Karbhari Shinde, Abdul Rasheed Mohammed, Vinod Kumar Goyal, Santosh Kumar Pandey, Vijay Sidram Benade, Venkatesh Goura, Venkateswarlu Jasti
  • HETEROALICYCLIC DERIVATIVES AND THEIR USE IN THE TREATMENT OF CNS DISORDERS
    Publication number: 20250092049
    Abstract: The present invention relates to heteroalicyclic compounds represented by the general formula (I), or their isotopic forms, stereoisomers, or pharmaceutically acceptable salts thereof. The present invention also describes a method of making such compounds, pharmaceutical compositions comprising such compounds and their use for the treatment or prevention of central nervous system related disorders.
    Type: Application
    Filed: January 11, 2023
    Publication date: March 20, 2025
    Applicant: SUVEN LIFE SCIENCES LIMITED
    Inventors: Ramakrishna NIROGI, Abdul Rasheed MOHAMMED, Anil Karbhari SHINDE, Narsimha BOGARAJU, Vinod Kumar GOYAL, Santosh Kumar PANDEY, Vijay Sidram BENADE, Pradeep JAYARAJAN, Ramkumar SUBRAMANIAN, Venkateswarlu JASTI
  • PYRROLO[1,2-b]-2-PYRIDAZINONE COMPOUNDS AS 5-HT4 RECEPTOR AGONISTS
    Publication number: 20250019386
    Abstract: The present invention relates to pyrrolo[1,2-b]-2-pyridazinone compounds of formula (I), or their isotopic forms, stereoisomers, or pharmaceutically acceptable salts thereof as 5-HT4 receptor agonists. The present invention also describes methods of making such compounds, pharmaceutical compositions comprising such compounds, and their use in the treatment of gastrointestinal disease or disorder.
    Type: Application
    Filed: January 10, 2023
    Publication date: January 16, 2025
    Applicant: SUVEN LIFE SCIENCES LIMITED
    Inventors: Ramakrishna NIROGI, Anil Karbhari SHINDE, Abdul Rasheed MOHAMMED, Vinod Kumar GOYAL, Santosh Kumar PANDEY, Vijay Sidram BENADE, Venkatesh GOURA, Venkateswarlu JASTI
  • TREATING BEHAVIORAL AND PSYCHOLOGICAL SYMPTOMS IN DEMENTIA PATIENTS
    Publication number: 20220409614
    Abstract: The present invention provides a method for treating behavioral and psychological symptoms in patient with dementia comprising administering an effective dose of pure 5-HT6 receptor antagonist, masupirdine or a pharmaceutically acceptable salt thereof either alone or in combination with an acetylcholinesterase inhibitor such as donepezil and NMDA (N-Methyl-D-aspartate) receptor antagonist, memantine. The present invention further provides use of the said compound in the manufacture of a medicament and pharmaceutical compositions comprising the said compounds intended for the treatment of the disorders described herein.
    Type: Application
    Filed: December 2, 2020
    Publication date: December 29, 2022
    Applicant: SUVEN LIFE SCIENCES LIMITED
    Inventors: Ramakrishna NIROGI, Anil Karbhari SHINDE, Pradeep JAYARAJAN, Satish JETTA, Raghava Chowdary PALACHARLA, Santosh Kumar PANDEY, Abdul Rasheed MOHAMMED, Vijay Sidram BENADE, Vinod Kumar GOYAL, Ramkumar SUBRAMANIAN, Jyothsna RAVULA, Venkateswarlu JASTI
  • Heteroaryl compounds as muscarinic M1 receptor positive allosteric modulators
    Patent number: 11234979
    Abstract: The present invention relates to compounds of formula (I), or their isotopic forms, stereoisomers, tautomers or pharmaceutically acceptable salt (s) thereof as muscarinic M1 receptor positive allosteric modulators (M1 PAMs).
    Type: Grant
    Filed: October 17, 2018
    Date of Patent: February 1, 2022
    Assignee: Suven Life Sciences Limited
    Inventors: Ramakrishna Nirogi, Abdul Rasheed Mohammed, Anil Karbhari Shinde, Srinivas Ravella, Vanaja Middekadi, Vinod Kumar Goyal, Pradeep Jayarajan, Saivishal Daripelli, Venkateswarlu Jasti
  • Fluoropiperidine compounds as pure 5-HT 6 receptor antagonists
    Patent number: 10973831
    Abstract: The present invention relates to fluoropiperidine compounds of formula (I), their stereoisomers, isotopic forms or pharmaceutically acceptable salts thereof as 5-HT6 receptor antagonists. In particular the present invention discloses the methods of preparation, pharmaceutical composition, combinations and use of fluoropiperidine compounds, their stereoisomers, isotopic forms or pharmaceutically acceptable salts thereof.
    Type: Grant
    Filed: August 6, 2018
    Date of Patent: April 13, 2021
    Assignee: SUVEN LIFE SCIENCES LIMITED
    Inventors: Ramakrishna Nirogi, Anil Karbhari Shinde, Abdul Rasheed Mohammed, Rajesh Kumar Badange, Kumar Bojja, Vinod Kumar Goyal, Santosh Kumar Pandey, Jagadeesh Babu Thentu, Venkateswarlu Jasti
  • HETEROARYL COMPOUNDS AS MUSCARINIC M1 RECEPTOR POSITIVE ALLOSTERIC MODULATORS
    Publication number: 20200237761
    Abstract: The present invention relates to compounds of formula (I), or their isotopic forms, stereoisomers, tautomers or pharmaceutically acceptable salt (s) thereof as muscarinic M1 receptor positive allosteric modulators (M1 PAMs). The present invention describes the preparation, pharmaceutical composition and the use of compound formula (I).
    Type: Application
    Filed: October 17, 2018
    Publication date: July 30, 2020
    Applicant: SUVEN LIFE SCIENCES LIMITED
    Inventors: Ramakrishna NIROGI, Abdul Rasheed Rasheed MOHAMMED, Anil Karbhari SHINDE, Srinivas RAVELLA, Vanaja MIDDEKADI, Vinod Kumar GOYAL, Pradeep JAYARAJAN, Saivishal DARIPELLI, Venkateswarlu JASTI
  • FLUOROPIPERIDINE COMPOUNDS AS PURE 5-HT 6 RECEPTOR ANTAGONISTS
    Publication number: 20200155560
    Abstract: The present invention relates to fluoropiperidine compounds of formula (I), their stereoisomers, isotopic forms or pharmaceutically acceptable salts thereof as 5-HT6 receptor antagonists. In particular the present invention discloses the methods of preparation, pharmaceutical composition, combinations and use of fluoropiperidine compounds, their stereoisomers, isotopic forms or pharmaceutically acceptable salts thereof.
    Type: Application
    Filed: August 6, 2018
    Publication date: May 21, 2020
    Applicant: SUVEN LIFE SCIENCES LIMITED
    Inventors: Ramakrishna NIROGI, Anil Karbhari SHINDE, Abdul Rasheed MOHAMMED, Rajesh Kumar BADANGE, Kumar BOJJA, Vinod Kumar GOYAL, Santosh Kumar PANDEY, Jagadeesh Babu THENTU, Venkateswarlu JASTI